Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05276622 · ClinicalTrials.gov registry record
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Terminated
- Registry status
- 64
- Enrollment target
NCT05276622: Clinical Trial study, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT05276622 is a clinical trial that was terminated before completion, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05276622 was terminated before completion, sponsored by UNC Lineberger Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 64 participants
- Enrollment target
Study Summary
This research study is explore the impact over time of multiple myeloma and its associated treatments on the physical and cognitive function and quality of life of patients and their care partners and how these impacts affect the overall illness experience.
Primary Outcome
Standardized National Institutes of Health Toolbox Cognition Battery (objective) (NIHTB-CB) will be used for the measure of cognitive function. The NIHTB-CB contains 7 computer-based instruments assessing 5 cognitive sub-domains: Language, Executive Function, Episodic Memory, Processing Speed, and Working Memory. The Composite Score is calculated using all subsets. Higher score =better level of cognitive functions.
Interventions
- OTHER Comprehensive Geriatric Assessment
- OTHER Qualitative patient-care partner interviews
- OTHER Surveys on well-being and function
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2022-02-08 |
| Est. Completion | 2023-10-03 |
Why NCT05276622 stopped before completion
NCT05276622 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Comprehensive Geriatric Assessment is the first listed.
NCT05276622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05276622 about?
NCT05276622 is a clinical study titled "Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)". This research study is explore the impact over time of multiple myeloma and its associated treatments on the physical and cognitive function and quality of life of patients and their care partners and how these impacts affect the overall illness experience.
What is the current status of trial NCT05276622?
This trial is currently terminated. The enrollment target is 64 participants. The study started on 2022-02-08. Estimated completion is 2023-10-03.
What interventions are being tested in trial NCT05276622?
The interventions under investigation include: Comprehensive Geriatric Assessment (OTHER), Qualitative patient-care partner interviews (OTHER), Surveys on well-being and function (OTHER).
Who is sponsoring clinical trial NCT05276622?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI